[1]
|
Hymas, N., et al. (1991) The neurology of obsessional slowness. Brain, 114, 2203-2233.
doi:10.1093/brain/114.5.2203
|
[2]
|
Anand, N., et al. (2011) Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: A prospective 1-year follow-up study. Journal of Anxiety Disorders, 7, 939-945.
doi:10.1016/j.janxdis.2011.05.007
|
[3]
|
Patel, S.R. and Simpson, H.B. (2010) Patient Preferences for OCD treatment. Journal of Clinical Psychiatry, 71, 1434-1439. doi:10.4088/JCP.09m05537blu
|
[4]
|
Masi, G., et al. (2010) Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 30, 688-693. doi:10.1097/JCP.0b013e3181fab7b1
|
[5]
|
Speismann, B.B., Storch, E.A. and Abramowitz, J.S. (2011) Postpartum obessive-compulsive disorder. Journal of Obstetric, Gynecologic, & Neonatal Nursing (JOGNN), 40, 680-690. doi:10.1111/j.1552-6909.2011.01294.x
|
[6]
|
Berle, J.O. (1999) Severe postpartum depression and psychosis—When is electroconvulsive therapy the treatment of choice? Tidsskrift for Den Norske Legeforening, 119, 3000-3003.
|
[7]
|
Geller, P., Klier, C. and Neugebauer, R. (2001) Anxiety disorders following miscarriage. Journal of Clinical Psychiatry, 62, 432-438. doi:10.4088/JCP.v62n0606
|
[8]
|
Mavrogiorgou, P., Illes, F. and Juckel, G. (2011) Perinatal obsessive-compulsive disorder. Fortschritte der Neurologie—Psychiatrie, 79, 507-516.
doi:10.1055/s-0031-1281597
|
[9]
|
Kuelz, A., Hohagen, F. and Voderholzer, U. (2004) Neuropsychological performance in obsessive-compulsive disorder: A critical review. Biological Psychiatry, 65, 185-236. doi:10.1016/j.biopsycho.2003.07.007
|
[10]
|
Chamberlain, S. and Menzies, L. (2009) Endophenotypes of obsessive-compulsive disorder: Rationale, evidence and future potential. Expert Review of Neurotherapeutics, 9, 1133-1146. doi:10.1586/ern.09.36
|
[11]
|
Krishna, R., et al. (2011) Neuropsychological performance in OCD: A study in medication-naive patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 1969-1976. doi:10.1016/j.pnpbp.2011.09.009
|
[12]
|
Berg, J.E. (2010) Is detoxification or tapering of benzodiazepine abuse advisable in an acute psychiatric clinic? Clinical Neuropsychiatry, 7, 18-21.
|
[13]
|
Kumawat, B., et al. (2007) Wilson’s disease presenting as isolated obsessive-compulsive disorder. Indian Journal of Medical Sciences, 61, 607-610.
doi:10.4103/0019-5359.37047
|